Assets of RedHill Biopharma Ltd. from 31 Dec 2016 to 31 Dec 2024

Taxonomy & unit
ifrs-full: USD
Summary
RedHill Biopharma Ltd. quarterly Assets in USD history and change rate from 31 Dec 2016 to 31 Dec 2024.
  • RedHill Biopharma Ltd. Assets for the quarter ending 31 Dec 2024 was $18,043,000, a 22% decline year-over-year.
Source SEC data
View on sec.gov
Assets, Quarterly (USD)
Assets, YoY Quarterly Change (%)

RedHill Biopharma Ltd. Quarterly Assets (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $18,043,000 -$5,004,000 -22% 31 Dec 2024 20-F 10 Apr 2025 2024 FY
Q2 2024 $22,024,000 -$13,013,000 -37% 30 Jun 2024 6-K 29 Aug 2024 2024 Q2
Q4 2023 $23,047,000 -$135,823,000 -85% 31 Dec 2023 20-F 10 Apr 2025 2024 FY
Q2 2023 $35,037,000 -$132,930,000 -79% 30 Jun 2023 6-K 17 Aug 2023 2023 Q2
Q4 2022 $158,870,000 -$22,318,000 -12% 31 Dec 2022 20-F 08 Apr 2024 2023 FY
Q2 2022 $167,967,000 -$35,706,000 -18% 30 Jun 2022 6-K 07 Nov 2022 2022 Q2
Q4 2021 $181,188,000 +$947,000 +0.52% 31 Dec 2021 20-F 28 Apr 2023 2022 FY
Q2 2021 $203,673,000 +$37,303,000 +22% 30 Jun 2021 6-K 26 Aug 2021 2021 Q2
Q4 2020 $180,241,000 +$106,142,000 +143% 31 Dec 2020 20-F 17 Mar 2022 2021 FY
Q2 2020 $166,370,000 +$116,675,000 +235% 30 Jun 2020 6-K 13 Aug 2020 2020 Q2
Q4 2019 $74,099,000 +$11,688,000 +19% 31 Dec 2019 20-F 18 Mar 2021 2020 FY
Q2 2019 $49,695,000 +$11,847,000 +31% 30 Jun 2019 6-K 23 Jul 2019 2019 H1
Q4 2018 $62,411,000 +$5,068,000 +8.8% 31 Dec 2018 20-F 04 Mar 2020 2019 FY
Q2 2018 $37,848,000 30 Jun 2018 6-K 30 Aug 2018 2018 Q2
Q4 2017 $57,343,000 -$16,869,000 -23% 31 Dec 2017 20-F 26 Feb 2019 2018 FY
Q4 2016 $74,212,000 31 Dec 2016 20-F 22 Feb 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.